Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaspar Rufibach

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Journal of Clinical Epidemiology|March 2, 2010
Use of Brier score to assess binary predictionsKaspar Rufibach
The International Journal of Biostatistics|May 23, 2012
A smooth ROC curve estimator based on log-concave density estimatesKaspar Rufibach
Biometrical Journal. Biometrische Zeitschrift|May 14, 2011
Selection models with monotone weight functions in meta analysisKaspar Rufibach
Pharmaceutical Statistics|November 28, 2018
Treatment effect quantification for time-to-event endpoints-Estimands, analysis strategies, and beyondKaspar Rufibach
Skeletal Radiology|July 30, 2010
Assessment of paired binary dataKaspar Rufibach
Pharmaceutical Statistics|August 29, 2019
Integrating phase 2 into phase 3 based on an intermediate endpoint while accounting for a cure proportion-With an application to the design of a clinical trial in acute myeloid leukemiaKaspar Rufibach, Dominik Heinzmann, Annabelle Monnet
Biometrical Journal. Biometrische Zeitschrift|December 17, 2024
Oncology Clinical Trial Design Planning Based on a Multistate Model That Jointly Models Progression-Free and Overall Survival EndpointsAlexandra Erdmann, Jan Beyersmann, Kaspar Rufibach
Contemporary Clinical Trials|January 9, 2016
Comparison of different clinical development plans for confirmatory subpopulation selectionKaspar Rufibach, Meng Chen, Hoa Nguyen
Statistics in Medicine|July 6, 2019
Joint modeling of progression-free and overall survival and computation of correlation measuresMatthias Meller, Jan Beyersmann, Kaspar Rufibach
Journal of Biopharmaceutical Statistics|November 6, 2014
Sequentially updating the likelihood of success of a Phase 3 pivotal time-to-event trial based on interim analyses or external informationKaspar Rufibach, Paul Jordan, Markus Abt
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Epidemiology|March 2, 2010
Use of Brier score to assess binary predictionsKaspar Rufibach
The International Journal of Biostatistics|May 23, 2012
A smooth ROC curve estimator based on log-concave density estimatesKaspar Rufibach
Biometrical Journal. Biometrische Zeitschrift|May 14, 2011
Selection models with monotone weight functions in meta analysisKaspar Rufibach
Pharmaceutical Statistics|November 28, 2018
Treatment effect quantification for time-to-event endpoints-Estimands, analysis strategies, and beyondKaspar Rufibach
Skeletal Radiology|July 30, 2010
Assessment of paired binary dataKaspar Rufibach
Pharmaceutical Statistics|August 29, 2019
Integrating phase 2 into phase 3 based on an intermediate endpoint while accounting for a cure proportion-With an application to the design of a clinical trial in acute myeloid leukemiaKaspar Rufibach, Dominik Heinzmann, Annabelle Monnet
Biometrical Journal. Biometrische Zeitschrift|December 17, 2024
Oncology Clinical Trial Design Planning Based on a Multistate Model That Jointly Models Progression-Free and Overall Survival EndpointsAlexandra Erdmann, Jan Beyersmann, Kaspar Rufibach
Contemporary Clinical Trials|January 9, 2016
Comparison of different clinical development plans for confirmatory subpopulation selectionKaspar Rufibach, Meng Chen, Hoa Nguyen
Statistics in Medicine|July 6, 2019
Joint modeling of progression-free and overall survival and computation of correlation measuresMatthias Meller, Jan Beyersmann, Kaspar Rufibach
Journal of Biopharmaceutical Statistics|November 6, 2014
Sequentially updating the likelihood of success of a Phase 3 pivotal time-to-event trial based on interim analyses or external informationKaspar Rufibach, Paul Jordan, Markus Abt
Pageof 9